LEPTIN AND VISFATIN AS PREDICTORS OF GESTATIONAL HYPERTENSIVE COMPLICATIONS IN OVERWEIGHT WOMEN
Open Access
- 15 June 2024
- journal article
- research article
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 81 (2) , 7-13
Abstract
Background. Over the past decades, fatty tissue has ceased to be just an energy depot, but as a source of hormone-like peptides - adipokines, such as leptin and visfatin. There is a direct correlation between body weight and the risk of developing gestational complications. Aim of this study was to determine prognostic value of leptin and visfatin in predicting gestational hypertensive complications in overweight women. Materials and methods. We examined 117 women divided into two groups: the main group included 68 overweight women, the control group included 49 women with normal body weight. Serum leptin and visfatin was established before pregnancy, in the first and third trimester. Results. In overweight women, gestational hypertension was observed in 20 women (29.4%) and preeclampsia in 25 women (36.8%). The concentration of leptin in the third trimester during gestational hypertension increased by 21.9%, by 20.2% in preeclampsia compared before pregnancy (p<0.05) and exceeded the value in uncomplicated pregnancy by 1.3 times (p<0.05). In main group during third trimester in case of gestational hypertensive complications, the concentration of visfatin was higher than in women without complications (p<0.05). In the groups of women with hypertensive conditions, we observed significantly higher concentrations of visfatin compared with the woman without complications. In main group in case of gestational hypertensive complications, the concentration of visfatin was higher than in women without complications on the third trimester. Conclusions. In overweight patients who developed hypertensive complications, leptin found to be 3.0 times higher before pregnancy and 2.0 times higher in the first trimester. Visfatin were found to be 1.2 times higher at both stages compared with control group. Leptin and visfatin may serve as qualitative predictors of hypertensive complications before pregnancy and during early gestation in overweight women.Keywords
This publication has 22 references indexed in Scilit:
- Longitudinal Study of Plasma Visfatin/Nicotinamide Phosphoribosyltransferase (NAMPT) Levels in Healthy Pregnant WomenReproductive Sciences, 2023
- Adipokines in obesity and metabolic-related-diseasesBiochimie, 2023
- Expression and regulation of visfatin/NAMPT in the porcine corpus luteum during the estrous cycle and early pregnancyAnimal Reproduction Science, 2023
- Preconceptual leptin levels in gestational diabetes and hypertensive pregnancyHypertension in Pregnancy, 2022
- Association between circulating visfatin and pre-eclampsia: a systematic review and meta-analysisThe Journal of Maternal-Fetal & Neonatal Medicine, 2020
- Can adipokine visfatin be a novel marker of pregnancy‐related disorders in women with obesity?Obesity Reviews, 2020
- Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsiaThe Journal of Maternal-Fetal & Neonatal Medicine, 2019
- Adipokine profiles in preeclampsiaThe Journal of Maternal-Fetal & Neonatal Medicine, 2019
- The role of visfatin (PBEF/Nampt) in pregnancy complicationsJournal of Reproductive Immunology, 2015
- Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidenceFertility and Sterility, 2008